Have any questions? 706-721-6582 or cts@augusta.edu
- (Reach-OB-23) A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
Clinical Trial
(Reach-OB-23) A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
This is an observational study to help advance new therapies for patients with Cystic Fibrosis who are not taking CFTR modulators. Participants in the study will take part in research visits to collect de-identified health information and specimens, like bloodwork for analysis. Participants duration of participation is up to 12 months.
Eligibility Criteria
- Inclusion Criteria: Subjects that have documentation of a Cystic Fibrosis diagnosis Subjects that are >12 years of age at Visit 1 Subjects are willing and able to adhere to the study visit schedule Exclusion Criteria: Subjects that are not clinically stable Subjects that are pregnant at Visit 1 or plan to get pregnant Subjects that have a history of lung transplantation
RESEARCH. INNOVATION. DISCOVERY.